The genetic instruments for IGF-1 were not available in the GWAS for ovarian cancer, invasive mucinous ovarian cancer, or endometrioid ovarian cancer, and no suitable proxy SNPs were available, meaning the causal effect of IGF-1 on these cancers could not be estimated. The gene discussed is IGF1; the disease is cancer.